Clopidogrel is an antiplatelet medication approved for managing unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) in patients receiving fibrinolytic therapy. Indications also include secondary prevention in cases of recent myocardial infarction, stroke, and peripheral arterial disease. Several additional FDA-approved indications expand its use in clinical practice.
Copyright © 2025, StatPearls Publishing LLC.